Skip to main content
Zelluna ASA logo

Zelluna ASA — Investor Relations & Filings

Ticker · ULTI ISIN · NO0010851603 LEI · 254900B4VALJZR9TL744 OL Manufacturing
Open in API
Filings indexed 483 across all filing types
Latest filing 2022-03-25 AGM Information
Country NO Norway
Listing OL ULTI

About Zelluna ASA

https://www.zelluna.com/

Zelluna ASA is a cell therapy company pioneering the development of T cell receptor (TCR) guided natural killer (NK) cell immunotherapies for the treatment of solid cancers. The company's proprietary TCR-NK platform is designed to combine the high-precision targeting of TCRs with the potent, innate anti-tumor activity of NK cells. This approach aims to overcome the challenges associated with treating solid tumors. Zelluna is focused on creating a new generation of allogeneic, "off-the-shelf" cell therapies. The mission is to deliver transformative and potentially curative treatments for patients with advanced solid cancers, addressing a significant unmet medical need.

Recent filings

Filing Released Lang Actions
Ultimovacs ASA: Notice of Annual General Meeting on 21 April 2022
AGM Information Classification · 100% confidence The document text is titled "Innkalling til generalforsamling" (Notice of Annual General Meeting) in Norwegian and "Notice of Annual General Meeting" in English. It explicitly details the date, time, and location for the General Meeting (21.04.2022) and provides forms for attendance registration and granting proxy votes. This content directly relates to the procedures and materials surrounding the Annual General Meeting (AGM). Therefore, the appropriate classification is AGM-R (AGM Information).
2022-03-25 English
Ultimovacs ASA: Notice of Annual General Meeting on 21 April 2022
AGM Information Classification · 100% confidence The document is explicitly titled 'INNKALLING TIL ORDINÆR GENERALFORSAMLING I ULTIMOVACS ASA' (Notice of Annual General Meeting in Ultimovacs ASA). The agenda items cover standard AGM topics such as approval of the annual accounts, remuneration guidelines, election of the board, and granting authorities to the board (including share capital increases and share buybacks). This content directly corresponds to the purpose of an Annual General Meeting notice and materials. Therefore, the classification is AGM-R.
2022-03-25 English
Ultimovacs ASA: Notice of Annual General Meeting on 21 April 2022
AGM Information Classification · 98% confidence The document explicitly states it is a 'Notice of Annual General Meeting' and provides the date, time, and location for the meeting. This directly corresponds to the definition of AGM Information (AGM-R). Although it is a notice, the content is the core material for the AGM itself, making AGM-R a more specific fit than a general Report Publication Announcement (RPA) or Regulatory Filing (RNS). The document length is short (998 chars), but the content is the official call/notice for the AGM, which is the primary purpose.
2022-03-25 English
Ultimovacs ASA: Annual Report 2021
Annual Report (ESEF) Classification · 100% confidence FY 2021
2022-03-25 English
Ultimovacs ASA: Annual Report 2021
Annual Report Classification · 100% confidence The document is titled 'Annual Report 2021' and contains comprehensive sections including a CEO statement, directors' report, financial statements, notes, and auditor's report for the Ultimovacs Group. It covers the full fiscal year 2021 and provides detailed operational and financial performance, fitting the definition of an Annual Report (10-K). FY 2021
2022-03-25 English
Ultimovacs ASA: Annual Report 2021
Report Publication Announcement Classification · 98% confidence The document explicitly states 'Ultimovacs ASA: Annual Report 2021' in the title and body. However, the text is a short press release announcing that the Board of Directors has approved the Annual Report for 2021 and directs the reader to find the PDF version 'as attachments to this release'. According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement stating that a report is attached or published should be classified as a Report Publication Announcement (RPA), not the full report itself (10-K). Although the content is about the Annual Report, the document's function here is to announce its publication.
2022-03-25 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.